Interactions of Obstructive Sleep Apnea With the Pathophysiology of Cardiovascular Disease, Part 1: JACC State-of-the-Art Review
JACC State-of-the-Art Review
Abstract
The American Heart Association considers sleep health an essential component of cardiovascular health, and sleep is generally a time of cardiovascular quiescence, such that any deviation from normal sleep may be associated with adverse cardiovascular consequences. Many studies have shown that both impaired quantity and quality of sleep, particularly with obstructive sleep apnea (OSA) and comorbid sleep disorders, are associated with incident cardiometabolic consequences. OSA is associated with repetitive episodes of altered blood gases, arousals, large negative swings in intrathoracic pressures, and increased sympathetic activity. Recent studies show that OSA is also associated with altered gut microbiota, which could contribute to increased risk of cardiovascular disease. OSA has been associated with hypertension, atrial fibrillation, heart failure, coronary artery disease, stroke, and excess cardiovascular mortality. Association of OSA with chronic obstructive lung disease (overlap syndrome) and morbid obesity (obesity hypoventilation syndrome) increases the odds of mortality.
Highlights
• | OSA is associated with increased cardiovascular risk, amplified by OHS and overlap syndromes. | ||||
• | The presentation and cardiovascular implications of OSA differ between men and women. | ||||
• | Potential mechanism linking sleep apnea to incident CVD may involve alterations in the gut microbiome. |
References
1. "Sleep-disordered breathing". 15th ed. Fuster & Hurst’s The Heart, 2022. 781-805.
2. "Life's Essential 8: updating and enhancing the American Heart Association's Construct of Cardiovascular Health: a Presidential Advisory from the American Heart Association". Circulation . 2022;146:e18-e43.
3. "Sleep disordered breathing and cardiovascular disease: JACC State-of-the-Art Review". J Am Coll Cardiol . 2021;78:608-624.
4. "Sympathetic-nerve activity during sleep in normal subjects". N Engl J Med . 1993;328:303-307.
5. "Slow-wave sleep is associated with incident hypertension: the Sleep Heart Health Study". Sleep . 2018;41:zsx179.
6. "Triggering of nocturnal arrhythmias by sleep-disordered breathing events". J Am Coll Cardiol . 2009;54:1797-1804.
7. "Insomnia and risk of cardiovascular disease". Chest . 2017;152:435-444.
8. "Sleep duration and mortality in patients with coronary artery disease". Am J Cardiol . 2019;123:874-881.
9. "Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Association". Circulation . 2021;144:e56-e67.
10. "Healthy sleep patterns and risk of incident arrhythmias". J Am Coll Cardiol . 2021;78:1197-1207.
11. "Adherence to a healthy sleep pattern is associated with lower risks of all-cause, cardiovascular and cancer-specific mortality". J Intern Med . 2022;291:64-71.
12. "Adherence to a healthy sleep pattern and incident heart failure: a prospective study of 408 802 UK Biobank participants". Circulation . 2021;143:97-99.
13. "Insomnia is associated with cortical hyperarousal as early as adolescence". Sleep . 2016;39:1029-1036.
14. "Short sleep duration and health outcomes: a systematic review, meta-analysis, and meta-regression". Sleep Med . 2017;32:246-256.
15. "Circadian variation in the frequency of onset of acute myocardial infarction". N Engl J Med . 1985;313:1315-1322.
16. "Morning increase in the time of onset of sustained ventricular tachycardia". Am J Cardiol . 1989;64:1204-1206.
17. "Circadian variation in the timing of stroke onset:a meta-analysis". Stroke . 1998;29:992-996.
18. "Molecular mechanisms underlying the circadian rhythm of blood pressure in normotensive subjects". Curr Hypertens Rep . 2020;22:50.
19. "Impact of the human circadian system, exercise, and their interaction on cardiovascular function". Proc Natl Acad Sci U S A . 2010;107:20541-20546.
20. "Circadian clock genes and the transcriptional architecture of the clock mechanism". J Mol Endocrinol . 2019;63:R93-R102.
21. "Evening chronotype is associated with elevated biomarkers of cardiometabolic risk in the EpiHealth cohort: a cross-sectional study". Sleep . 2022;45:zsab226.
22. "Sleep irregularity and subclinical markers of cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis". J Am Heart Assoc . 2023;12:e027361.
23. "Dosing time matters". Science . 2019;365:547-549.
24. "Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial". Eur Heart J . 2020;41:4565-4576.
25. "Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial". Lancet . 2022;400:1417-1425.
26. "New insights on chronotherapy in hypertension: is timing everything?"Curr Hypertens Rep . 2020;22:32.
27. "Chronotherapy for morning blood pressure surge in hypertensive patients: a systematic review and meta-analysis". BMC Cardiovasc Disord . 2021;21:274.
28. "Diagnosis and management of obstructive sleep apnea: a review". JAMA . 2020;323:1389-1400.
29. "Headache in sleep apnea syndrome: epidemiology and pathophysiology". Cephalalgia . 2014;34:752-755.
30. "Update on persistent excessive daytime sleepiness in OSA". Chest . 2020;158:776-786.
31. "Sleep apnea: types, mechanisms, and clinical cardiovascular consequences". J Am Coll Cardiol . 2017;69:841-858.
32. "Gut microbiota mediate vascular dysfunction in a murine model of sleep apnoea: effect of probiotics". Eur Respir J . 2023;61:2200002.
33. "Obstructive sleep apnea-induced hypertension is associated with increased gut and neuroinflammation". J Am Heart Assoc . 2023;12:e029218.
34. "Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease". Front Cardiovasc Med . 2020;7:22.
35. "Obstructive sleep apnea and inflammation: proof of concept based on two illustrative cytokines". Int J Mol Sci . 2019;20:459.
36. "Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome". Circulation . 2005;112:2660-2667.
37. "Obstructive sleep apnoea syndrome—an oxidative stress disorder". Sleep Med Rev . 2003;7:35-51.
38. "Proteomic biomarkers of sleep apnea". Sleep . 2020;43:zsaa086.
39. "Precision medicine in patients with resistant hypertension and obstructive sleep apnea: blood pressure response to continuous positive airway pressure treatment". J Am Coll Cardiol . 2015;66:1023-1032.
40. "Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans". J Appl Physiol (1985) . 1989;67:2095-2100.
41. "Sympathetic neural mechanisms in obstructive sleep apnea". J Clin Invest . 1995;96:1897-1904.
42. "Pathophysiology of sleep apnea". Physiol Rev . 2010;90:47-112.
43. "Ganglionated plexi ablation suppresses chronic obstructive sleep apnea-related atrial fibrillation by inhibiting cardiac autonomic hyperactivation". Front Physiol . 2021;12:640295.
44. "Obstructive sleep apnea is related to alterations in fecal microbiome and impaired intestinal barrier function". Sci Rep . 2023;13:778.
45. "Gut microbiota in hypertensive patients with versus without obstructive sleep apnea". J Clin Hypertens (Greenwich) . 2022;24:1598-1605.
46. "OSA is associated with the human gut microbiota composition and functional potential in the population-based Swedish CardioPulmonary bioImage Study". Chest . 2023;164:503-516.
47. "Chronic sleep disruption alters gut microbiota, induces systemic and adipose tissue inflammation and insulin resistance in mice". Sci Rep . 2016;6:35405.
48. "Temporal changes in coronary artery function and flow velocity reserve in mice exposed to chronic intermittent hypoxia". Sleep . 2022;45:zsac131.
49. "Fecal microbiota transplantation from mice exposed to chronic intermittent hypoxia elicits sleep disturbances in naive mice". Exp Neurol . 2020;334:113439.
50. "Causal relationship between gut microbiota and obstructive sleep apnea". Arch Gerontol Geriatr . 2023;113:105052.
51. "Diagnostic and therapeutic approach to sleep disorders, high blood pressure and cardiovascular diseases: a consensus document by the Italian Society of Hypertension (SIIA)". High Blood Press Cardiovasc Prev . 2021;28:85-102.
52. "Hypertension and sleep apnea". Can J Cardiol . 2015;31:889-897.
53. "Systemic and pulmonary hypertension in obstructive sleep apnea". In: Principles and Practices of Sleep Medicine . 2022. 1440-1452.
54. "Prospective study of the association between sleep disordered breathing and hypertension". N Engl J Med . 2000;342:1378-1384.
55. "Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea". Chest . 2004;125:112-117.
56. "2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults:executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". J Am Coll Cardiol . 2018;71:2199-2269.
57. "Echocardiographic changes with positive airway pressure therapy in obesity hypoventilation syndrome. Long-term Pickwick randomized controlled clinical trial". Am J Respir Crit Care Med . 2020;201:586-597.
58. "ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association". J Am Coll Cardiol . 2009;53:1573-1619.
59. "Impact of sleep on arrhythmogenesis". Circ Arrhythm Electrophysiol . 2009;2:450-459.
60. "Sleep-disordered breathing and cardiac arrhythmias". Can J Cardiol . 2015;31:928-934.
61. "Roles of adrenergic and cholinergic stimulation in spontaneous atrial fibrillation in dogs". J Am Coll Cardiol . 2004;43:483-490.
62. "Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation". J Am Coll Cardiol . 2007;49:565-571.
63. "Breathless nights and heart flutters: understanding the relationship between obstructive sleep apnea and atrial fibrillation". Heart Rhythm . 2023;20:1267-1273.
64. "Associations of obstructive sleep apnea with atrial fibrillation and continuous positive airway pressure treatment: a review". JAMA Cardiol . 2018;3:532-540.
65. "Effect of continuous positive airway pressure on arrhythmia in atrial fibrillation and sleep apnea: a randomized controlled trial". Am J Respir Crit Care Med . 2021;204:573-582.
66. "The impact of continuous positive airway pressure treatment on the recurrence of atrial fibrillation post cardioversion: a randomized controlled trial". Int J Cardiol . 2019;278:133-136.
67. "Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea". Am J Respir Crit Care Med . 2007;176:706-712.
68. "Circadian pattern of life-threatening ventricular arrhythmia in patients with sleep-disordered breathing and implantable cardioverter-defibrillators". Heart Rhythm . 2011;8:657-662.
69. "Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study". Am J Respir Crit Care Med . 2006;173:910-916.
70. "Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea". Thorax . 2005;60:781-785.
71. "PFO and right-to-left shunting in patients with obstructive sleep apnea". J Clin Sleep Med . 2012;8:375-380.
72. "Patent foramen ovale closure in obstructive sleep apnea improves blood pressure and cardiovascular function". Hypertension . 2015;66:1050-1057.
73. "Wake-up stroke and TIA due to paradoxical embolism during long obstructive sleep apnoeas: a cross-sectional study". Thorax . 2013;68:97-104.
74. "Day-night pattern of sudden death in obstructive sleep apnea". N Engl J Med . 2005;352:1206-1214.
75. "Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the Sleep Heart Health study". Circulation . 2010;122:352-360.
76. "Effect of positive airway pressure on cardiovascular outcomes in coronary artery disease patients with nonsleepy obstructive sleep apnea. The RICCADSA randomized controlled trial". Am J Respir Crit Care Med . 2016;194:613-620.
77. "Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAAC study): a randomized controlled trial". Lancet Respir Med . 2020;8:359-367.
78. "CPAP for prevention of cardiovascular events in obstructive sleep apnea". N Engl J Med . 2016;375:919-931.
79. "Apneas of heart failure and phenotype-guided treatments: part one: OSA". Chest . 2020;157:394-402.
80. "Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure". Circulation . 2010;121:1598-1605.
81. "Influence of obstructive sleep apnea on mortality in patients with heart failure". J Am Coll Cardiol . 2007;49:1625-1631.
82. "Nocturnal hypoxaemia is associated with increased mortality in stable heart failure patients". Eur Heart J . 2016;37:1695-1703.
83. "OSA and prognosis after acute cardiogenic pulmonary edema: the OSA-CARE study". Chest . 2017;152:1230-1238.
84. "In-hospital management of sleep apnea during heart failure hospitalization: a randomized controlled trial". J Card Fail . 2020;26:705-712.
85. "Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure". J Am Coll Cardiol . 2005;45:2008-2011.
86. "Obstructive sleep apnea and its treatment in aging: effects on Alzheimer's disease biomarkers, cognition, brain structure and neurophysiology". Neurobiol Dis . 2020;145:105054.
87. "Obstructive sleep apnea and stroke: the mechanisms, the randomized trials, and the road ahead". Sleep Med Rev . 2022;61:101568.
88. "Sleep patterns and the risk of acute stroke: results from the INTERSTROKE international case-control study". Neurology . 2023;100:e2191-e2203.
89. "Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association". Stroke . 2014;45:2160-2236.
90. "Obesity hypoventilation syndrome: a state-of-the-art review". Respir Care . 2010;55:1347-1362.discussion 1363-1345.
91. "Long-term clinical effectiveness of continuous positive airway pressure therapy versus non-invasive ventilation therapy in patients with obesity hypoventilation syndrome: a multicentre, open-label, randomised controlled trial". Lancet . 2019;393:1721-1732.
92. "Trends in obesity prevalence by race and Hispanic origin—1999-2000 to 2017-2018". JAMA . 2020;324:1208-1210.
93. "Chronic hypercapnia in obstructive sleep apnea-hypopnea syndrome". Sleep . 1994;17:416-423.
94. "Respiratory determinants of diurnal hypercapnia in obesity hypoventilation syndrome. What does weight have to do with it?"Ann Am Thorac Soc . 2014;11:945-950.
95. "Endothelial dysfunction and specific inflammation in obesity hypoventilation syndrome". PLoS One . 2009;4:e6733.
96. "Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study". Am J Epidemiol . 2004;160:521-530.
97. "Eight hours of nightly continuous positive airway pressure treatment of obstructive sleep apnea improves glucose metabolism in patients with prediabetes. A randomized controlled trial". Am J Respir Crit Care Med . 2015;192:96-105.
98. "A randomized controlled trial of continuous positive airway pressure on glucose tolerance in obese patients with obstructive sleep apnea". Sleep . 2016;39:35-41.
99. "COPD-OSA overlap syndrome: evolving evidence regarding epidemiology, clinical consequences, and management". Chest . 2017;152:1318-1326.
100. "Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome". Am J Respir Crit Care Med . 2010;182:325-331.
101. "Risk of new-onset atrial fibrillation in elderly patients with the overlap syndrome: a retrospective cohort study". J Geriatr Cardiol . 2013;10:129-134.
102. "Comorbid obstructive sleep apnoea and chronic obstructive pulmonary disease and the risk of cardiovascular disease". J Thorac Dis . 2018;10:S4253-S4261.
103. "Cardiovascular outcomes and all-cause mortality in patients with obstructive sleep apnea and chronic obstructive pulmonary disease (overlap syndrome)". Ann Am Thorac Soc . 2019;16:71-81.
104. "Impact of positive airway pressure therapy adherence on outcomes in patients with obstructive sleep apnea and chronic obstructive pulmonary disease". Am J Respir Crit Care Med . 2022;206:197-205.
105. "Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial". Lancet Respir Med . 2014;2:698-705.
106. "The epidemiology of obstructive sleep apnea: a population health perspective". Am J Respir Crit Care Med . 2002;165:1217-1239.
107. "Gender differences in sleep and sleep-disordered breathing". Clin Chest Med . 2004;25:257-268.
108. "Sleep disturbances during pregnancy and adverse maternal and fetal outcomes:a systematic review and meta-analysis". Sleep Med Rev . 2021;58:101436.
109. "Female sex and gender in lung/sleep health and disease. Increased understanding of basic biological, pathophysiological, and behavioral mechanisms leading to better health for female patients with lung disease". Am J Respir Crit Care Med . 2018;198:850-858.
110. "Sex influences endothelial function in sleep-disordered breathing". Sleep . 2004;27:1113-1120.
111. "The effects of gender and age on REM-related sleep-disordered breathing". Sleep Breath . 2008;12:259-264.
112. "Sex-specific associations of obstructive sleep apnea risk with patient characteristics and functional outcomes after acute myocardial infarction: evidence from the VIRGO study". J Am Heart Assoc . 2023;12:e027225.
113. "Obstructive sleep apnea in obese community-dwelling children: the NANOS study". Sleep . 2014;37:943-949.
114. "Sympathetic and catecholaminergic alterations in sleep apnea with particular emphasis on children". Front Neurol . 2012;3:7.
115. "Activity-adjusted 24-hour ambulatory blood pressure and cardiac remodeling in children with sleep disordered breathing". Hypertension . 2008;51:84-91.
116. "Genome-wide gene expression profiling in children with non-obese obstructive sleep apnea". Sleep Med . 2009;10:75-86.
117. "Single-cell RNA-seq uncovers cellular heterogeneity and provides a signature for paediatric sleep apnoea". Eur Respir J . 2023;61:2201465.
118. "Sleep disordered breathing and mortality:eighteen-year follow-up of the Wisconsin sleep cohort". Sleep . 2008;31:1071-1078.
119. "Sleep-disordered breathing and mortality:a prospective cohort study". PLoS Med . 2009;6:e1000132.